Merck KGaA provides schistosomiasis treatment in Madagascar
This article was originally published in Scrip
Executive Summary
Madagascar has become one of the first African countries to receiveMerck KGaA's Cesol 600 (praziquantel 600mg) tablets for the treatment of schistosomiasis, under its World Health Organization (WHO) agreement to provide $80 million worth of tablets to tackle the disease.